Incathlab: Transcontinental Collaborative Experience on Covid-19 & Cardiac Patients: Before and After the Breakout
This content was supplied by our valued media partner; incathlab To view this interesting webinar on the management of the COVID-19 pandemic for cardiologists, please click the link below: https://www.incathlab.com/en/lives/16-others/67-others/2528-transcontinental-collaborative-experience-on-covid-19-cardiac-patients-before-and-after-the-breakout?autoplay=1 Program COVID-19: Current worldwide status Eric Eeckhout & Max Amor Heart and COVID-19 Houng-Bang Liew Practical setup of the cathl lab in COVID times Jack […]
This content was supplied by our valued media partner; incathlab To view this interesting webinar on the management of the COVID-19 pandemic for cardiologists, please click the link below: https://www.incathlab.com/en/lives/16-others/67-others/2525-how-to-manage-cardiac-patients-during-the-covid-19-period Program Compare and discuss the different cardiac department organizations across Europe to face COVID-19 pandemic Italy – Gabriele Gasparini Spain – Javier Escaned France – Thierry Lefèvre […]
Chairpersons: John William Eikelboom (Hamilton, Canada), Gregory Yh Lip Liverpool, United Kingdom) Subtitle: Sponsored by Boehringer Ingelheim Learning Objectives: To evaluate the key milestones and innovations for non-Vitamin K antagonist oral anticoagulants (NOACs) in the past 10 year, and outline how these advances can inform treatment choices in patients with atrial fibrillation (AF) – To […]
Chairpersons: Christopher Paul Cannon (Boston, United States of America), Dominick Joseph Angiolillo (Jacksonville, United States of America) Subtitle: Sponsored by Boehringer Ingelheim Learning Objectives: To review how the presentation of the RE-LY results 10 years ago heralded a decade of innovation in the non-Vitamin K antagonist oral anticoagulant (NOAC) treatment landscape – To assess the […]
Rex Richmond Impulse Dynamics ; For more information, please visit https://impulse-dynamics.com/
Fletcher Hu Product Manager – Edan Instruments Inc. For more information, please visit www.edan.com.cn
Walden Wei Sales Manager, Borsam For more information, please visit https://en.bioxtime.com/
Fabio Rangoni President – CARDIOLINE For more information, please visit http://cardioline.com/
Dr Werner Kommer Specialist in Internal Medicine and a Cardiology General Practitioner Jörg Domes Sales Director – Acarix For more information, please visit www.acarix.com
Based on the patient characteristics of an elderly AF patient with renal impairment Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data to support the dabigatran treatment decision for this patient
Based on the patient characteristics of an AF patient with cardiovascular comorbidities Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data, GLORIA AF and RE-DUAL PCI to support the dabigatran treatment decision for this patient
Dabigatran, a direct Thrombin Inhibitor, Reduces the risk of an Intracerebral Haemorrhage: Protection of the blood brain Barrier
This is a video showing the MOA of thrombin inhibition on intracranial haemorrhage. It shows how dabigatran, a thrombin inhibitor minimises thrombin mediated damage and preserves the brain barrier, thereby minimising intracranial hemorage. It showcases the RE-LY trial as well as the confirmation of the trial by RWE.
Congress Presentation presented at AHA 2017 given by Dr. Chris Cannon with slides on a neutral background ( only Study branding) Including Q&A with Dr. Cannon and Dr. Hohnloser on FAQs related to the study results as well as the clinical implications of the results. Q&A 1: What may be the implication of the RE-DUAL […]
Neurologist’s Perspective of Reversal for Thrombolysis or ICH with Prof. Dr. Martin GrondThis adaptable 6 min video presents neurology cases from real clinical practice.
At ACC 2017 the RE-CIRCUIT study was presented in the Late-Breaking Clinical Trials session. Here we have a series of Q&A videos presented by Dr. Hugh Calkins Q&A 1: How do the absolute major bleeding event rates seen in RE-CIRCUIT for dabigatran etexilate and warfarin relate to those usually seen in clinical practice? Q&A 2: […]
Communicate RE-LY data including subgroups data and leverage expert opinion from Dr. John W. Eikelboom to cover: Overview of safety/efficacy profile established in RE-LY
Scott Hao Global Product Manager for Cardiovascular Ultrasound – highlighting Siemens Healthineers flagship ultrasound system For more information, please visit https://www.siemens-healthineers.com/en-uk/
Interview with Oscar Oseroff, Secretary General: World Society of Arrhythmias. In this interview he invites fellow friends and colleagues to join him at the World Congress of Arrhythmias (WSA 2019) in Buenos Aires, Argentina between 2nd – 4th of November 2019. Filming took place at the World Society of Arrhythmias stand at ESC 2019, Paris, […]
Join Dr. Chugh as he discusses how hypertension affects heart disease and what steps you can take to treat and manage your condition.
Birth defects of the heart, known as a congenital heart defects, or CHDs, affect the structure of a baby’s heart and the way it works. CHDs are the most common birth defect in babies born in the US. About 1 in 100 babies is born with a CHD. The most common type of CHD is […]
Adult congenital heart disease specialist, pediatric cardiologist Michael Jay Campbell, MD practices at Duke Children’s Hospital & Health Center, Duke Children’s and WakeMed Children’s Specialty Services and Duke University Hospital.
A deep vein thrombosis (DVT) is a serious condition that is a medical emergency. Find out what causes DVT and learn about the research the British Heart Foundation are funding to try and prevent it.
UCLA cardiologist Renna Patel, MD, talks about stroke prevention at a community event at Torrance South Bay YMCA. Dr. Patel is Director of the UCLA Women’s Heart Health Program in the South Bay.
Dr Narbeh Melikian explains what intervention cardiology is when compared to traditional cardiology
Why do heart doctors care so much about your legs? How can a cardiologist care for your whole body? What is an interventional cardiologist in the first place? In this video, Dr. Daniel Ice, MD answers all of these questions and more.
Michele Ciccarelli, University of Salerno, Italy speaks on “The role of imaging in detecting subtle modifications in cardiovascular disease”. This movie is part of “UltraSound imaging in cardiac and vascular medicine: from pre-clinical to clinical studies” Course, 21-22 February 2019, ICGEB Trieste, Italy.
Sandor Batkai, Medizinische Hochschule Hannover (MHH), Germany speaks on “The translational value of US imaging in heart failure drug development”. This movie is part of “UltraSound imaging in cardiac and vascular medicine: from pre-clinical to clinical studies” Course, 21-22 February 2019, ICGEB Trieste, Italy.
Hypertension is the most commonly treated condition in adult primary care offices throughout the United States; affecting more than 60% of individuals over the age of 65. Treatment guidelines have been fairly uniform historically. However, new guidelines and recommendations are prompting discussion among nephrologists. Jamie Johnston, MD, professor of nephrology at UPMC, explains the details […]
In this video Dr. Gillard lectures on the basic anatomy and physiology of the heart’s conduction system. Students, please listen to this prior to the beginning of the electrophysiology/electrocardiogram section of the course.
DO NEW STUDIES/DEVICES TIP THE BALANCE TO EARLIER LVAD IMPLANTATION AS DESTINATION THERAPY? (Invited Lecture) Maryl R. Johnson, M.D.
The British Heart Foundation explains what congenital heart disease is, and highlights the most common conditions. Learn more about BHF research into congenital heart disease at bhf.org.uk/repairing-heartsSHOW MORE
What is ischemic heart disease coronary artery disease (CAD), and what is the relation to ischemic heart disease, atherosclerosis, & myocardial infarctions?
Animated infographic Video summarizing the RE-DUAL PCI Results of different subgroups like ACS / non ACS, Ticagrelor vs Clopidogrel, Renal Function in less than three minutes.
Safety of uninterrupted dabigatran for cardiovascular interventions in the GLORIA-AF Registry Program (summarized by Prof Gregory Lip). An educational video summarizing data presented at EHRA, Barcelona 2018.
The results from the full cohort analysis of the REVERSE-AD study provide compelling evidence for idarucizumab’s ability to immediately, completely and sustainably reverse the anticoagulant effect of dabigatran. This video summarizes the key results of the RE-VERSE AD study and shows the importance of specific reversibility in the context of anticoagulation
Animated infographic Video summarizing the RE-DUAL PCI Results published in NEJM comprehensively in two minutes.
Dual Antithrombotic Therapy with Dabigatran in AF Patients post PCI – Expert Interview with Dr. Jur ten Berg
Expert interview with Dr. Jur ten Berg about dual antithrombotic therapy with Dabigatran in AF patients post PCI. In the interview he focuses mainly on new subanalyses, presented at ACC Does the Discontinuation of ASA in the Warfarin-TT Arm Influence the Treatment Outcomes Vs Dabigatran-DT? Landmark analysis What treatment regimens were compared in the RE-DUAL […]
Interview series with Professor Stefan Hohnloser about dual antithrombotic therapy with Dabigatran in AF patients post PCI Should dabigatran dual therapy be the default strategy for most patients with AF and ACS? Which dabigatran dose would be recommended for patients with AF and ACS Post-PCI? How do the data reported on concomitant use of ticagrelor […]
Dr. Dominick Angiolillo summarizes the results of the RE-DUAL PCI study showing the safety of dabigatran dual therapy post-PCI with doses approved for stroke prevention in AF. He also shows data on subgroup analysis in patients with ACS / no ACS as an index event and subgroup analysis looking at results dependent on the P2Y12 […]
In the video Dr. Gupta summarized the results of the RE-CIRCUIT study confirming the safety profile of dabigatran also in the setting of catheter ablation in AF patients. He explains that based on the RE-CIRCUIT results, interruption of dabigatran prior to ablation is no longer warranted, as reflected in current expert guidance for performing AF […]
An infographic publication video summarizing the results of the RE-CIRCUIT study recently published in NEJM comprehensively in less than 2 minutes.
Summary of GLORIA-AF Final Phase II: Two-year safety and effectiveness of dabigatran in patients with atrial fibrillation (summarized by Prof Gregory Lip). An educational video summarizing data presented at EHRA, Barcelona 2018.
The series of infographic animations communicate the consistency of results, how RWE supports the favorable safety profile and the importance of RWE evidence. From Clinical Studies to RWE This infographic animation communicates the consistency of results, how RWE supports the favourable safety profile and the importance of RWE evidence. Safety proven by RWE This infographic […]
Recent discoveries in epigenetics could soon make a clinical difference for children with attention-deficit/hyperactivity disorder, autism spectrum disorder, and other conditions, according to an expert.